This page may contain stale information. Last updated: 2026-09-24
Definition
AI drug discovery applies machine learning and computational simulation to design drug candidates — including antigens, proteins, and small molecules — reducing reliance on trial-and-error wet-lab screening.
Key Points
-
2026-09-23: enveda 2B valuation; three clinical-stage AI-discovered candidates; PRISM platform (2026-09-23-enveda-311m-ai-drug-funding)
-
2026-09-18: anthropic denies wet lab is for drug discovery — Novo Nordisk partnership context (2026-09-18-anthropic-wet-biology-lab)
-
2026 milestone: Cambridge/diosynvax completed first human trial of vaccine whose active component was fully AI-designed (Sarbeco universal coronavirus vaccine)
-
Method: AI-designed “super-antigen” targeting conserved viral features across a virus family
-
Phase 1 (39 volunteers): safe; modest cross-reactive antibodies; efficacy unproven
-
Delivery: DNA vaccine via needle-free microfluidic jet
-
Broader pipeline: flu and Ebola vaccine designs in development
Phase 1 safety ≠ clinical efficacy. Avoid "AI cures pandemics" hype framing.